Detalhe da pesquisa
1.
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.
Am J Gastroenterol
; 115(8): 1217-1225, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32355123
2.
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.
Clin Gastroenterol Hepatol
; 17(9): 1850-1859.e4, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30448598
3.
Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy.
Cancers (Basel)
; 16(5)2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473248